BioAtla, Inc. (BCAB)
OTCMKTS · Delayed Price · Currency is USD
1.080
-0.610 (-36.09%)
At close: Sep 1, 2026

BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of 1.80 million. The enterprise value is 6.12 million.

Market Cap1.80M
Enterprise Value 6.12M

Important Dates

The next estimated earnings date is Friday, November 6, 2026.

Earnings Date Nov 6, 2026
Ex-Dividend Date n/a

Share Statistics

BioAtla has 1.67 million shares outstanding. The number of shares has increased by 28.86% in one year.

Current Share Class 1.67M
Shares Outstanding 1.67M
Shares Change (YoY) +28.86%
Shares Change (QoQ) +10.66%
Owned by Insiders (%) 7.48%
Owned by Institutions (%) 12.17%
Float 1.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.21
PB Ratio -0.05
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.72
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.20

Current Ratio 0.20
Quick Ratio 0.17
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.25
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -105.86%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 269.43%
Weighted Average Cost of Capital (WACC) 1.89%
Revenue Per Employee 207,317
Profits Per Employee -767,171
Employee Count41
Asset Turnover 0.46
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -95.26% in the last 52 weeks. The beta is 0.69, so BioAtla's price volatility has been lower than the market average.

Beta (5Y) 0.69
52-Week Price Change -95.26%
50-Day Moving Average 3.44
200-Day Moving Average 12.47
Relative Strength Index (RSI) 15.74
Average Volume (20 Days) 138,807

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 1.70

Income Statement

In the last 12 months, BioAtla had revenue of 8.50 million and -31.45 million in losses. Loss per share was -22.74.

Revenue 8.50M
Gross Profit -16.06M
Operating Income -31.03M
Pretax Income -31.45M
Net Income -31.45M
EBITDA -30.83M
EBIT -31.03M
Loss Per Share -22.74
Full Income Statement

Balance Sheet

The company has 1.54 million in cash and 5.86 million in debt, with a net cash position of -4.32 million or -2.59 per share.

Cash & Cash Equivalents 1.54M
Total Debt 5.86M
Net Cash -4.32M
Net Cash Per Share -2.59
Equity (Book Value) -36.24M
Book Value Per Share -21.79
Working Capital -16.76M
Full Balance Sheet

Cash Flow

Operating Cash Flow -23.48M
Capital Expenditures n/a
Depreciation & Amortization 195,000
Net Borrowing 7.13M
Free Cash Flow -23.48M
FCF Per Share -14.09
Full Cash Flow Statement

Margins

Gross Margin -188.92%
Operating Margin -365.00%
Pretax Margin -370.05%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -28.86%
Shareholder Yield -28.86%
Earnings Yield -1,748.04%
FCF Yield -1,305.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on April 6, 2026. It was a reverse split with a ratio of 0.02.

Last Split Date Apr 6, 2026
Split Type Reverse
Split Ratio 0.02

Scores

BioAtla has an Altman Z-Score of -92.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -92.9
Piotroski F-Score 3